The aim of this study was to investigate the impact of anti-HBc (HBcAb) positivity on the progression of liver fibrosis (Fibrosis-4 score >3.25) in the Italian cohort of HIV-infected individuals naïve to antiretroviral treatment (ICONA).
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients
Andreoni, Massimo;A. Di Biagio;L. Taramasso;M. Bassetti;
2021-01-01
Abstract
The aim of this study was to investigate the impact of anti-HBc (HBcAb) positivity on the progression of liver fibrosis (Fibrosis-4 score >3.25) in the Italian cohort of HIV-infected individuals naïve to antiretroviral treatment (ICONA).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
malagnino OFID 2021.pdf
accesso aperto
Tipologia:
Documento in versione editoriale
Dimensione
195.34 kB
Formato
Adobe PDF
|
195.34 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
